Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

Journal of Pathology

Volumn 195, Issue 5, 2001, Pages 530-536

  Ann Florenes V ^a   Mari Maelandsmo G ^b   Faye, R ^a   Nesland, J M ^a   Holm, R ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Clinicl outcome; Cyclin A; Ki 67; Melanoma; Nodular; Superficial

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PARAFFIN; PROTEIN P21;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; SCORING SYSTEM; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN A; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035668485     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1007     Document Type: Article

References (28)

1. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
2. Principles of CDK regulation
3. Inhibitors of mammalian G1 cyclin-dependent kinases
4. Cancer cell cycles
5. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A
6. Role for cyclin A in the dependence of mitosis on completion of DNA replication
7. Cyclin A is required at two points in the human cell cycle
8. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes
9. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase
10. Cyclin D1 and human neoplasia
11. Deregulation of cyclin E in breast cancer
12. Interaction between human cyclin A and adenovirus E1A-associated p107 protein
13. Cyclin A and the retinoblastoma gene product complex with a common transcription factor
14. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
15. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas
16. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma
17. Expression of cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis
18. Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
19. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma
20. Expression of cyclin A and D proteins in prostate cancer and their relation to clinicopathological variables and patient survival
21. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness
22. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer
23. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions
24. Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: Reduced expression in metastatic lesions
25. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
26. Ki-67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions
27. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free survival
28. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 (KIPI)